CCL2 and hepatocellular carcinoma: ETV4 enhances the expression of PD-L1 and chemokine CCL2 in HCC cells, leading to the infiltration of MDSCs and TAMs, the suppression of CD8+ T cells, and the facilitation of HCC metastasis (70).